Huntsman Past Earnings Performance
Past criteria checks 0/6
Huntsman has been growing earnings at an average annual rate of 5.9%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 1.3% per year.
Key information
5.9%
Earnings growth rate
8.1%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 1.3% |
| Return on equity | 1.0% |
| Net Margin | -0.3% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Huntsman makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6,111 | -17 | 694 | 108 |
| 30 Sep 23 | 6,358 | -21 | 692 | 109 |
| 30 Jun 23 | 6,863 | 80 | 682 | 112 |
| 31 Mar 23 | 7,437 | 274 | 726 | 115 |
| 31 Dec 22 | 8,023 | 448 | 669 | 119 |
| 30 Sep 22 | 8,485 | 1,105 | 605 | 124 |
| 30 Jun 22 | 8,571 | 1,207 | 649 | 128 |
| 31 Mar 22 | 8,025 | 1,119 | 687 | 125 |
| 31 Dec 21 | 7,670 | 996 | 715 | 129 |
| 30 Sep 21 | 7,226 | 762 | 784 | 130 |
| 30 Jun 21 | 6,639 | 607 | 766 | 128 |
| 31 Mar 21 | 6,262 | 413 | 778 | 131 |
| 31 Dec 20 | 5,421 | 257 | 642 | 115 |
| 30 Sep 20 | 6,007 | 169 | 770 | 123 |
| 30 Jun 20 | 6,184 | 83 | 785 | 125 |
| 31 Mar 20 | 6,721 | 225 | 784 | 131 |
| 31 Dec 19 | 6,797 | 393 | 780 | 131 |
| 30 Sep 19 | 6,961 | 169 | 772 | 146 |
| 30 Jun 19 | 7,242 | 401 | 782 | 146 |
| 31 Mar 19 | 6,978 | 312 | 780 | 143 |
| 31 Dec 18 | 7,604 | 376 | 789 | 145 |
| 30 Sep 18 | 7,986 | 529 | 792 | 143 |
| 30 Jun 18 | 8,187 | 419 | 784 | 143 |
| 31 Mar 18 | 8,721 | 555 | 791 | 142 |
| 31 Dec 17 | 6,845 | 406 | 751 | 132 |
| 30 Sep 17 | 8,059 | 413 | 781 | 137 |
| 30 Jun 17 | 7,721 | 360 | 771 | 136 |
| 31 Mar 17 | 7,095 | 360 | 737 | 134 |
| 31 Dec 16 | 7,518 | 334 | 759 | 137 |
| 30 Sep 16 | 7,946 | 214 | 819 | 139 |
| 30 Jun 16 | 8,753 | 238 | 866 | 146 |
| 31 Mar 16 | 10,065 | 147 | 959 | 155 |
| 31 Dec 15 | 8,139 | 395 | 791 | 143 |
| 30 Sep 15 | 10,918 | 56 | 987 | 169 |
| 30 Jun 15 | 11,164 | 189 | 977 | 168 |
| 31 Mar 15 | 11,412 | 277 | 972 | 164 |
| 31 Dec 14 | 11,578 | 331 | 950 | 158 |
| 30 Sep 14 | 11,332 | 410 | 927 | 148 |
| 30 Jun 14 | 11,290 | 288 | 943 | 143 |
| 31 Mar 14 | 11,132 | 216 | 932 | 140 |
| 31 Dec 13 | 11,079 | 133 | 934 | 140 |
| 30 Sep 13 | 10,993 | 50 | 975 | 145 |
| 30 Jun 13 | 10,892 | 100 | 957 | 145 |
Quality Earnings: HTR is currently unprofitable.
Growing Profit Margin: HTR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HTR is unprofitable, but has reduced losses over the past 5 years at a rate of 5.9% per year.
Accelerating Growth: Unable to compare HTR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HTR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.4%).
Return on Equity
High ROE: HTR has a negative Return on Equity (1.01%), as it is currently unprofitable.